Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital Portfolio News / By Karina Tin August 1, 2023 Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital Read More »
Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer Portfolio News / By Karina Tin July 31, 2023 Neurona Therapeutics Appoints James Stutz as Chief Financial Officer and Chief Business Officer Read More »
Synthekine Doses First Patient in Phase 1 Clinical Trial of Orthogonal IL-2 and CD19 CAR-T Combination Therapy, STK-009 + SYNCAR-001, for Treatment of CD19+ Hematologic Malignancies Portfolio News / By Karina Tin July 27, 2023 Synthekine Doses First Patient in Phase 1 Clinical Trial of Orthogonal IL-2 and CD19 CAR-T Combination Therapy, STK-009 + SYNCAR-001, for Treatment of CD19+ Hematologic Malignancies Read More »
Circle Pharma Strengthens Its Executive Leadership Team With Two Senior Appointments in Clinical Development Portfolio News / By Karina Tin July 26, 2023 Circle Pharma Strengthens Its Executive Leadership Team With Two Senior Appointments in Clinical Development Read More »
Circle Pharma Achieves Major Milestone with the Selection of a Clinical Development Candidate Directly Inhibiting Cyclins A and B Portfolio News / By Karina Tin July 19, 2023 Circle Pharma Achieves Major Milestone with the Selection of a Clinical Development Candidate Directly Inhibiting Cyclins A and B Read More »
Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer Portfolio News / By Karina Tin July 17, 2023 Atavistik Bio Appoints Bryan Stuart as Chief Executive Officer Read More »
Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update Portfolio News / By Karina Tin July 13, 2023 Nurix Therapeutics Reports Second Quarter Fiscal 2023 Financial Results and Provides a Corporate Update Read More »
ORIC Pharmaceuticals Announces $85 Million Private Placement Financing Portfolio News / By Karina Tin June 26, 2023 ORIC Pharmaceuticals Announces $85 Million Private Placement Financing Read More »
Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions Portfolio News / By Karina Tin June 23, 2023 Carmot Therapeutics Highlights Clinical Data from its Pipeline of Treatments for Obesity and Diabetes at the 83rd American Diabetes Association Scientific Sessions Read More »
Escient Pharmaceuticals Announces Positive Results From Phase 1 Study of EP262, A First-In-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders Portfolio News / By Karina Tin June 20, 2023 Escient Pharmaceuticals Announces Positive Results From Phase 1 Study of EP262, A First-In-Class Oral MRGPRX2 Antagonist for Mast Cell Mediated Disorders Read More »
